This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kuramochi, Y. Articles by Morita, T. Search for Related Content PubMed PubMed Citation Articles by Kuramochi, Y. Articles by Morita, T. Social Bookmarking                         What's this?

Cardiac tamponade due to systemic lupus erythematosus in patient with Prader-Willi syndrome after growth hormone therapy

kuramochi2005{at}yahoo.co.jp

T. Kato

M. Sudou

H. Sugano

H. Takagi

T. Morita

We present a 16-year old girl with Prader-Willi syndrome who developed cardiac tamponade as an initial finding of systemic lupus erythematosus. Until one year prior to this episode, she had received growth hormone treatment for nine years. The association among Prader-Willi syndrome, growth hormone treatment and systemic lupus erythematosus is discussed. Lupus (2007) 16, 447—449.

Key Words: growth hormone • Prader-Willi syndrome • systemic lupus erythematosus

Lupus, Vol. 16, No. 6, 447-449 (2007)
DOI: 10.1177/0961203307077995


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?